Bayesian Capital Management, LP Chroma Dex Corp. Transaction History
Bayesian Capital Management, LP
- $582 Million
- Q1 2025
A detailed history of Bayesian Capital Management, LP transactions in Chroma Dex Corp. stock. As of the latest transaction made, Bayesian Capital Management, LP holds 13,500 shares of CDXC stock, worth $82,890. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,500Holding current value
$82,890% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding CDXC
# of Institutions
149Shares Held
24.4MCall Options Held
190KPut Options Held
14.1K-
Vanguard Group Inc Valley Forge, PA3.54MShares$21.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$19.1 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA1.99MShares$12.2 Million6.26% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.28MShares$7.88 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.18MShares$7.24 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $420M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...